The global butyric acid market size was reached at USD 374.2 million in 2022 and it is projected to hit around USD 578.3 million by 2032 with a noteworthy CAGR of 4.5% from 2023 to 2032.
To Access our Exclusive Data Intelligence Tool with 15000+ Database, Visit: Precedence Statistics
The Asia Pacific butyric acid market size accounted for USD 164.6 million in 2022 and is estimated to reach around USD 264.8 million by 2032, growing at a CAGR of 4.9% from 2023 to 2032.
Due to the fast-growing pharmaceutical and agricultural industries, where butyric acid is used in animal feed, Asia Pacific will likely become the region with the greatest market for butyric acid. During the forecast period, agro-based economies like India will likely hold a sizable market share.
The Asia Pacific butyric acid market, will likely increase due to several important players in the area and quickly growing end-use industries. The need for butyric acid to manufacture biofuels in North America and Europe will be facilitated by strict regulations by environmental regulators against antibiotics in animal feed.
When bacteria ferment carbohydrates and dietary fibre, a colourless carboxylic acid known as butyric or butanoic acid is produced. It can also be found in milk, butter, cheese, vegetable oils, and animal fats. It can also be used as a precursor to creating different biofuels. It is produced industrially through the chemical synthesis of feedstocks derived from petroleum and through the fermentation of starch or sugar in a solution of calcium carbonate and putrefying cheese.
As a result, it demonstrates several positive traits like affordability, sustainability, and low greenhouse gas emissions. Because of these, butyric acid is widely used in various businesses, including those that produce animal feed, medications, chemical intermediates, perfume goods, and food and beverages.
The enormous worldwide pharmaceutical business growth is one of the key factors supporting a positive outlook for the market. Pharmaceutical companies employ butyric acid to create medications to treat cancer, irritable bowel syndrome, and obesity (IBS). Additionally, market growth is being boosted by the growing use of butyric acid to improve the nutritional value of animal feed.
It helps to prevent microbial infections and diseases in pigs, poultry, fish, and cattle, as well as to improve digestive health. Additionally, the industry is expanding as more products are being employed in creating biofuels, quickly replacing conventional gasoline and other fuel substitutes.
The demand for animal feed is rising, especially for swine and poultry, propelling the butyric acid market's expansion. Furthermore, renewable butyric acid demand is rising in the food, flavour, and pharmaceutical industries.
The emphasis on R and D activities has turned to alternative fuel sources due to the rise in petroleum prices and the ongoing decline in petroleum availability, combined with the rising need for clean energy sources. Security of supply, a reduction in greenhouse gas emissions, and long-term viability are just a few of the many environmental advantages of biofuels.
| Report Coverage | Details |
| Market Size in 2023 | USD 389.2 Million |
| Market Size by 2032 | USD 578.3 Million |
| Growth Rate from 2023 to 2032 | CAGR of 4.5% |
| Largest Market | Asia Pacific |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Segments Covered | By Product, By Application and By Derivatives |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America and Middle East & Africa |
The main drivers of the butyric acid market's expansion are the increasing demand from various end-user sectors and the prohibition of antibiotic usage in animal feed in some nations. However, the smell of butyric acid is a significant barrier to market expansion. The food and flavour sectors' renewable butyric acid rising demand may create a sizable business opportunity in the years to come.
The rising demand for packaged foods due to shifting customer preferences is a key driver of industry expansion. The market is driven by butyric acid, and as meat consumption rises, so does butyric acid production in finished goods.
One of the main reasons influencing the market's optimistic outlook is the substantial growth of the pharmaceutical business globally. Pharmaceutical companies employ butyric acid to create medications that help with weight management, cancer treatment, and irritable bowel syndrome (IBS).
The expanding prevalence of animal diseases has led to a rise in the usage of butyric acid in feed for animals across several geographical markets. Asia has very low per capita meat consumption compared to industrialised nations like Europe and North America. However, meat consumption in the area will likely soar due to increased earnings and urbanisation.
One of the main reasons influencing the market's optimistic outlook is the substantial growth of the pharmaceutical business globally. Pharmaceutical companies employ butyric acid to create medications that help with weight management, cancer treatment, and irritable bowel syndrome (IBS).
The expanding prevalence of animal diseases has led to a rise in the usage of butyric acid in feed for animals across several geographical markets. Asia has very low per capita meat consumption compared to industrialised nations like Europe and North America. However, meat consumption in the area will likely soar due to increased earnings and urbanisation.
Drivers
The Increasing use of butyric acid to prevent CVS disorders
The increasing use of butyric acid to prevent extensive cardiovascular diseases, including Heart failure, Atherosclerosis, High blood pressure, and stroke, significantly drives the growth of the butyric acid market.
According to the National library of medicine, Oral butyrate can inhibit the development of atherosclerosis by lowering macrophage adhesion and migration and boosting plaque stability. These processes are related to reduced pro-inflammatory cytokines, decreased CD36 in macrophages and endothelial cells, and decreased NF-B activation. Such as, a metabolite produced by gut bacteria called butyric acid reduces arterial blood pressure by activating the GPR41/43 receptors and the colon-vagus nerve.
In addition, the gut microbiota impacted butyric acid production, which altered the acetylation level and tissue healing after myocardial infarction. Furthermore, Butyric acid is used to treat and prevent the development of various gastrointestinal disorders, including diarrhoea, intestinal inflammations, functional abnormalities, dysbiosis, and symptoms that arise after surgery or chemotherapy. The standard butyric acid doses (150–300 mg) range between 1.5–3% and 15–30% of the average daily demand.
The rising number of oncology patients
Short-chain fatty acid sodium butyrate (NaB), created by bacterial fermentation of indigestible dietary fibre, has been shown to have anti-tumour effects in several tumour types, including colorectal cancer (CRC). According to the National Center of Biotechnology Information, phenyl butyric acid (PBA) has a growth-inhibitory impact on gastric cancer cells related to cell cycle changes.
The cell cycle was stopped in moderately differentiated gastric cancer (Adenocarcinomas) cells at the G0/G1 and G2/M stages. The cell cycle was stopped in low-differentiated gastric cancer cells at the G0/G1 and S phases. In addition,
According to the American Society of Clinical Oncology, India is anticipated to have 1,392,179 cancer patients, In 2020. Breast (57.0%), cervix uteri (60.0%), head and neck (66.6%), and stomach (50.8%) cancer were among the most commonly diagnosed tumours at a locally advanced stage.
However, lung cancer was more commonly identified with distant metastasis in men (44.0%) and females (47.6%). Furthermore, according to the World Cancer Research Fund International, there were 18.1 million new cancer cases worldwide. 9.3 million of these cases included men, while 8.8 million were women in 2020.
The flourishing use of ethyl butyrate for synthetic flavours, perfumes and cosmetics is continuously driving the growth of the butyric acid market.
Ethyl butyrate is a versatile, very affordable flavouring ingredient that is frequently used in the production of food and nutrition products. Apricots, bubble gum, cherry, fig, guava, mango, orange, peach, pineapple, and plum are some of their flavouring agents.
According to the Penta International Corporation, ethyl butyrate is used to produce BUTYL-2-METHYL BUTYRATE, BUTYL-2-METHYL BUTYRATE NATURAL, ETHYL BUTYRATE FCC, ETHYL BUTYRATE NATURAL, ISOAMYL-2-METHYL BUTYRATE NATURAL among others. These apply to manufacturing flavouring used in food or perfume and as a solvent.
In addition, In the fragrance industry, ethyl butyrate is frequently used to provide products such as Lotions and creams for antiperspirants, deodorants and lipsticks. It is profoundly used as a Bath and Shower Gel, Shampoo and Conditioner, Soap (both solid and liquid), and Talcum Powder.
Opportunity
Stringent guidelines for the use of antibiotics in animal feed
Antibiotics can no longer be added to feed to stimulate the development of animals and poultry, according to FDA regulations. It was also vital to look at alternatives because the European Union has banned antibiotics. Thus, it is anticipated that such strict rules would open up opportunities for butyric acid to replace antibiotics in animal feed.
In addition, the butyric acid market is growing due to demand from several end-use industries, VirtualExpo Group, Kemin Industries Inc., Thermo Fisher Scientific, and many other industries that use butyric acid for animal feed. The food and flavour industries' increasing demand for renewable butyric acid provides a considerable market opportunity in the years ahead.
Restrains
The odour of butyric acid is a significant barrier to the market.
The butyric acid odour is a significant barrier to market expansion. Inhaling butyric acid can have adverse effects and be absorbed through the skin, and contact can cause serious skin and eye burns and severe eye damage.
The nose, throat, and lungs might get irritated while inhaling butyric acid. 3-4% of the fat molecules in butter are made from butyric acid. In addition, it is a by-product of anaerobic fermentation and is typically found in dairy products. Thus, the references to parmesan cheese and butter. Butyric acid is just what gives vomit its distinctive odour smell.
The hazardous impact of butyric acid on human health and the environment
The respiratory tract and mucous membranes are irritated by inhalation, which increases the risk of nausea and vomiting. Mouth and stomach discomfort occur from eating. Eye contact may result in severe harm. Burns might result from skin contact; the chemical is readily absorbed through the skin and could cause damage in this manner.
A headache, nausea, vomiting, and light-headedness from overexposure are all possible side effects. Higher doses may cause unconsciousness. In addition, several medical professionals advise against taking butyric acid supplements if the user is pregnant or breastfeeding. Butyrate has also been reported to cause symptoms in those who need different fibre levels, such as those with bloating or a sensitive stomach (food intolerance).
Impact of Covid-19
The COVID-19 pandemic has impacted the global market for butyric acid in three key ways: directly affecting supply and demand, disrupting the market and supply chain, and having an economic impact on businesses and financial markets. Flight cancellations, restaurant closures, travel bans, and prohibitions on all indoor events are just a few of the many effects of the outbreak.
Other effects include the declaration of a state of emergency in more than 40 countries, a significant slowdown in the supply chain, stock market volatility, declining business confidence, rising public panic, and uncertainty regarding the future.
Before the COVID-19 outbreak, the food and beverage, animal feed, pulp and paper, and pharmaceutical industries were the key growth drivers of the natural butyric acid industry. However, in 2020, these businesses had to scale back their activities due to value chain disruptions brought on by closing domestic and international borders.
Due to limitations put in place by government agencies in several nations, the COVID-19 epidemic hindered the main supply networks for raw materials and disrupted production processes. However, economies began to gradually restart their activities in 2021, which benefited the world economy.
Manufacturers were able to work at full capacity by the end of 2021. Many individuals from different countries will have received all recommended vaccinations, allowing them to focus on bridging the supply and demand gap. Additionally, the pharmaceutical industry's increased need for natural butyric acid during the COVID-19 epidemic favoured the market.
Based on Product, the market is divided into renewable and synthetic. The market share will likely be dominated by renewable butyric acid. The synthetic segment is estimated to observe the fastest expansion. The factors can be ascribed to the rising synthetic butyric acid usage in APAC nations and its attractiveness as a raw material in many sectors due to its inexpensive and effective fermentation technique.
The natural butyric acid segment will likely dominate the market due to the increasing demand for natural ingredients in food and beverage products and the growing awareness about the health benefits of natural butyric acid. The synthetic butyric acid segment will likely grow at a moderate rate, driven by the increasing demand for industrial chemicals and pharmaceutical products.
Global Butyric Acid Market, By Product, 2022-2032 ($Million)
| By Product | 2022 | 2023 | 2027 | 2032 |
| Renewable | 243.2 | 253.3 | 301.1 | 381.7 |
| Synthetic | 131.0 | 135.8 | 158.6 | 196.6 |
Based on application, the market is divided into animal feed, chemical intermediate, perfume, pharmaceuticals, food and flavors, and others. The segment for animal feed will likely have the greatest CAGR during the foreseeable time. These factors can be linked to the sharp rise in interest in high-quality animal feed.
The animal feed segment is the largest application for butyric acid, followed by the food and beverages and pharmaceuticals segment.
Global Butyric Acid Market, By Application, 2022-2032 ($Million)
| By Application | 2022 | 2023 | 2027 | 2032 |
| Chemical Intermediates | 59.9 | 62.5 | 74.9 | 96.0 |
| Animal Feed | 203.9 | 211.5 | 247.3 | 307.1 |
| Pharmaceuticals | 43.0 | 44.8 | 53.3 | 67.7 |
| Food & Flavors | 44.9 | 47.0 | 57.0 | 74.0 |
| Others | 22.5 | 23.3 | 27.2 | 33.5 |
These key players have implemented various organic and inorganic growth methods to improve their position in this market, including mergers and acquisitions, expansions, new product launches, joint ventures, agreements, partnerships, and others.
Segments Covered in the Report:
By Product
By Application
By Derivatives
By Geography
PROCEED TO BUY :
ASK FOR SAMPLE
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
